Skip to main content
. 2010 Aug 29;31(24):3006–3016. doi: 10.1093/eurheartj/ehq325

Figure 1.

Figure 1

Cumulative incidence of (A) the primary composite of cardiovascular death, myocardial infarction and stroke and (B) total mortality and (C) major bleeding in the ticagrelor (solid lines) and clopidogrel (dotted lines) groups in patients with diabetes at baseline (blue lines) and no diabetes (red lines).